Sponsor	Allergan
Subject	Managing Macular Edema following Retinal Vein Occlusion: Newer ParadigmsSpeaker
Time	12:40-13:40
Venue	Room 10
Chair	YoungHee YOON
Speakers	Vishali GUPTA Szilard KISS HyeongGon YU
Synopsis	Retinal Vein Occlusion (RVO) is one of the more common retinal vascular diseases, and is second only to diabetic retinopathy, in incidence. Macular Edema is the leading cause of reduced vision in patients with RVO. Results from recent randomized clinical trials, provide us a number of evidence based choices to manage macular edema following RVO more effectively. This talk examines randomized controlled trial evidence as well as clinical case experiences with intravitreal controlled release biodegradable Dexamethasone Implant